Literature DB >> 8880719

Tumefactive demyelinating lesions.

A P Dagher1, J Smirniotopoulos.   

Abstract

We studied 21 cases of pathologically confirmed tumefactive demyelinating lesions and reviewed the spectrum of tumefactive demyelinating lesions in the literature. Radiological features and clinical data were reviewed to characterize the lesions as consistent with a known demyelinating disease, most notably multiple sclerosis. Atypical clinical or radiological features (other than tumefaction) were noted. Most lesions were part of a clinical and/or radiological picture consistent with multiple sclerosis. No case strongly suggestive of variants or related diseases, such as Schilder's disease or Balo's concentric sclerosis, were found. There was one case suggestive of acute disseminated encephalomyelitis. Features which help distinguish the lesions from tumour are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8880719     DOI: 10.1007/bf00626098

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  22 in total

1.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.

Authors:  F Fazekas; H Offenbacher; S Fuchs; R Schmidt; K Niederkorn; S Horner; H Lechner
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

2.  Balo's concentric sclerosis: a rare form of multiple sclerosis manifested as a dominant cerebral mass without other white matter lesions on MR.

Authors:  M M Tersegno; D R Reich
Journal:  AJR Am J Roentgenol       Date:  1993-04       Impact factor: 3.959

3.  Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy.

Authors:  G M Nesbit; G S Forbes; B W Scheithauer; H Okazaki; M Rodriguez
Journal:  Radiology       Date:  1991-08       Impact factor: 11.105

4.  Relapsing central and peripheral demyelinating diseases. Unusual pathologic features.

Authors:  S M de la Monte; A H Ropper; G R Dickersin; N L Harris; J A Ferry; E P Richardson
Journal:  Arch Neurol       Date:  1986-06

5.  Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.

Authors:  J J Kepes
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

6.  Primary demyelinating disease simulating glioma of the corpus callosum: report of three cases.

Authors:  K G Rieth; G Di Chiro; L D Cromwell; P E McKeever; P L Kornblith; C V Kufta; A B Pleet
Journal:  J Neurosurg       Date:  1981-10       Impact factor: 5.115

7.  Schilder's myelinoclastic diffuse sclerosis.

Authors:  C M Poser; F Goutières; M A Carpentier; J Aicardi
Journal:  Pediatrics       Date:  1986-01       Impact factor: 7.124

8.  Multiple sclerosis mimicking primary brain tumor.

Authors:  S B Hunter; W E Ballinger; J J Rubin
Journal:  Arch Pathol Lab Med       Date:  1987-05       Impact factor: 5.534

9.  Multiple ring enhancement in a case of acute reversible demyelinating disease in childhood suggestive of acute multiple sclerosis.

Authors:  O Ishihara; Y Yamaguchi; T Matsuishi; E Yano; Y Nakamura; J Tateishi; F Yamashita
Journal:  Brain Dev       Date:  1984       Impact factor: 1.961

10.  Multiple sclerosis with clinical and radiological features of cerebral tumour.

Authors:  H J Sagar; C P Warlow; P W Sheldon; M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

View more
  35 in total

1.  Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.

Authors:  C H Toh; K-C Wei; S-H Ng; Y-L Wan; M Castillo; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

2.  Negative association of Epstein-Barr virus or herpes simplex virus-1 with tumefactive central nervous system inflammatory demyelinating disease.

Authors:  Takao Kiriyama; Hiroshi Kataoka; Takahiko Kasai; Akitaka Nonomura; Satoshi Ueno
Journal:  J Neurovirol       Date:  2010-11-11       Impact factor: 2.643

Review 3.  MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Authors:  A Seewann; C Enzinger; M Filippi; F Barkhof; A Rovira; A Gass; D Miller; X Montalban; A Thompson; T Yousry; M Tintore; N de Stefano; J Palace; M Rovaris; C Polman; F Fazekas
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

4.  Late-onset tumefactive multiple sclerosis.

Authors:  Taizo Takeuchi; Mitsuhiro Ogura; Morio Sato; Nobuyuki Kawai; Hirohiko Tanihata; Isao Takasaka; Hiroki Minamiguchi; Motoki Nakai; Toru Itakura
Journal:  Radiat Med       Date:  2008-11-22

5.  MRI findings and pathological features in early-stage glioblastoma.

Authors:  Makoto Ideguchi; Koji Kajiwara; Hisaharu Goto; Kazutaka Sugimoto; Sadahiro Nomura; Eiji Ikeda; Michiyasu Suzuki
Journal:  J Neurooncol       Date:  2015-05-05       Impact factor: 4.130

6.  Synthetic MRI for Clinical Neuroimaging: Results of the Magnetic Resonance Image Compilation (MAGiC) Prospective, Multicenter, Multireader Trial.

Authors:  L N Tanenbaum; A J Tsiouris; A N Johnson; T P Naidich; M C DeLano; E R Melhem; P Quarterman; S X Parameswaran; A Shankaranarayanan; M Goyen; A S Field
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

7.  Versatile utilization of real-time intraoperative contrast-enhanced ultrasound in cranial neurosurgery: technical note and retrospective case series.

Authors:  Ilya Lekht; Noah Brauner; Joshua Bakhsheshian; Ki-Eun Chang; Mittul Gulati; Mark S Shiroishi; Edward G Grant; Eisha Christian; Gabriel Zada
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

Review 8.  Tumefactive demyelinating lesions: nine cases and a review of the literature.

Authors:  Lei Xia; Song Lin; Zhong-cheng Wang; Shao-wu Li; Li Xu; Jing Wu; Shu-yu Hao; Chuan-chuan Gao
Journal:  Neurosurg Rev       Date:  2009-01-27       Impact factor: 3.042

9.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

10.  Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

Authors:  Rajan Jain; Shehanaz Ellika; Norman L Lehman; Lisa Scarpace; Lonni R Schultz; Jack P Rock; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-10-15       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.